v3.25.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES    
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $ (33,201,683) $ (15,920,362)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 26,957 17,429
Amortization expense 2,975,628 1,257,534
Finance charges 1,835,080 1,287,916
Change in fair value of embedded derivative instruments (2,562,027) 0
Change in fair value of warrants 1,616,972 0
Bad debt expense 241,396 158,620
Change in value of forward purchase agreement 5,350,127 2,312,116
Stock compensation expense 7,134,163 1,942,036
Loss (gain) on sale of assets (980,197) (13,778)
Dividend expense 2,044,866 368,699
Non-cash interest expense 1,202,281 167,265
Impairment of intangible assets 6,631,862 105,676
Changes in assets and liabilities:    
Accounts receivable (436,334) (307,716)
Prepaid expenses and other current assets 1,539,567 (1,244,356)
Right of use asset, net of lease liability 2,676 31,034
Accounts payable and accrued expenses 1,558,077 907,164
Warrant and embedded derivative liability 1,726,251 0
Deferred revenue 63,649 105,751
NET CASH USED IN OPERATING ACTIVITIES (3,230,688) (8,824,972)
INVESTING ACTIVITIES    
Cash portion of consideration paid to acquire Preferred Dental   (1,559,144)
Cash portion of consideration paid to acquire FeatherPay, LLC (500,000) 0
Cash portion of consideration paid to acquire Verifi Dental LLC (370,000) 0
Cash portion of consideration paid to acquire Teamworx, LLC   0
Investment in forward purchase agreement 0 (7,796,672)
Proceeds from sale of assets 1,733,612 28,000
Purchases of capital assets 0 (159,878)
Additions to capitalized software (1,403,028) (727,021)
NET CASH USED IN INVESTING ACTIVITIES (539,416) (10,214,715)
FINANCING ACTIVITES    
Net proceeds from debt 3,662,361 7,796,753
Payments on debt (1,322,002) (1,235,399)
Proceeds from issuance of common stock 303,619 2,881,024
Conversion of convertible debt into common stock 108,945 0
Proceeds from issuance of series A convertible preferred stock 0 18,312,897
Effect of merger, net of transactions 0 (7,692,383)
NET CASH PROVIDED BY FINANCING ACTIVITIES 2,752,923 20,062,892
NET CHANGE IN CASH (1,017,181) 1,023,205
CASH AT BEGINNING OF THE YEAR 1,219,358 196,153
CASH AT END OF THE YEAR 202,177 1,219,358
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Cash paid during the period for interest 224,237 18,750
Noncash Investing and Financing Items    
Stock issued for acquisitions 6,245,000 400,000
Stock issued for conversion of notes payable $ 2,039,479 $ 5,765,656

Source

PDF HTML 10-K Filing
ZIP XLS HTML XBRL